- Home
- CRAI vs OCUL Comparison
CRAI vs OCUL Comparison
Compare CRAI & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRAI
- OCUL
- Stock Information
- Founded
- CRAI 1965
- OCUL 2006
- Country
- CRAI United States
- OCUL United States
- Employees
- CRAI N/A
- OCUL N/A
- Industry
- CRAI Other Consumer Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- CRAI Consumer Discretionary
- OCUL Health Care
- Exchange
- CRAI Nasdaq
- OCUL Nasdaq
- Market Cap
- CRAI 1.2B
- OCUL 1.2B
- IPO Year
- CRAI 1998
- OCUL 2014
- Fundamental
- Price
- CRAI $200.99
- OCUL $7.00
- Analyst Decision
- CRAI Buy
- OCUL Strong Buy
- Analyst Count
- CRAI 1
- OCUL 7
- Target Price
- CRAI $212.00
- OCUL $16.71
- AVG Volume (30 Days)
- CRAI 31.8K
- OCUL 917.6K
- Earning Date
- CRAI 02-20-2025
- OCUL 03-10-2025
- Dividend Yield
- CRAI 0.97%
- OCUL N/A
- EPS Growth
- CRAI 25.05
- OCUL N/A
- EPS
- CRAI 6.74
- OCUL N/A
- Revenue
- CRAI $687,414,000.00
- OCUL $61,442,000.00
- Revenue This Year
- CRAI $10.80
- OCUL $11.40
- Revenue Next Year
- CRAI $3.40
- OCUL $13.58
- P/E Ratio
- CRAI $29.98
- OCUL N/A
- Revenue Growth
- CRAI 10.17
- OCUL 6.45
- 52 Week Low
- CRAI $111.20
- OCUL $4.06
- 52 Week High
- CRAI $214.01
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- CRAI 58.98
- OCUL 31.92
- Support Level
- CRAI $187.88
- OCUL $7.14
- Resistance Level
- CRAI $214.01
- OCUL $7.42
- Average True Range (ATR)
- CRAI 6.43
- OCUL 0.37
- MACD
- CRAI 1.70
- OCUL -0.02
- Stochastic Oscillator
- CRAI 61.46
- OCUL 0.76
About CRAI CRA International Inc.
CRA International Inc is a U.S.-based advisory firm that provides economic, financial, and management consultancy services. The company advises clients on economic and financial issues relating to litigation and regulatory proceedings and helps businesses set important business strategies and solve performance-related issues. The company's clients include domestic and foreign companies, government agencies, public and private utilities, and national and international trade associations. CRA International generates majority of its revenue from the United States.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.